ArticleCase reports in dermatology
A Case Report of Non-Uremic Calciphylaxis Refractory to Treatment Requiring Multidisciplinary Care.
Article in Case reports in dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Calciphylaxis, also known as calcific uremic arteriolopathy, is a rare, severe disease that causes diffuse skin ischemia and necrotic lesions with a high mortality rate. This disease most commonly affects patients with end-stage renal disease (ESRD). However, there are reported cases of patients developing calciphylaxis without ESRD, known as non-uremic calciphylaxis (NUC). NUC is especially rare, and little is known about its pathophysiology and treatment. Case Presentation: We present the case of a 47-year-old male with multiple comorbidities but no history of ESRD who presented initially with left leg lesions eventually diagnosed as calciphylaxis. Multimodal treatment with extensive rehabilitation and multiple amputations, along with palliative care, was necessary as the patient did not respond to standard treatment of thiosulfate. Conclusion: NUC is a rare disease, and awareness of its existence is essential for earlier diagnosis and optimal management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.